• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含 2,2'-联吡啶衍生物的甲基环戊二烯基钌化合物具有很强的抗癌活性和多药耐药潜力。

Methyl-cyclopentadienyl Ruthenium Compounds with 2,2'-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential.

机构信息

Centro de Química Estrutural , Faculdade de Ciências da Universidade de Lisboa , Campo Grande , 1749-016 Lisboa , Portugal.

Drug Resistance and Membrane Proteins Team , Molecular Biology and Structural Biochemistry Laboratory , UMR 5086 CNRS-UCBL1, IBCP 7 Passage du Vercors , 69 367 Lyon Cedex 07, France.

出版信息

Inorg Chem. 2018 Apr 16;57(8):4629-4639. doi: 10.1021/acs.inorgchem.8b00358. Epub 2018 Apr 3.

DOI:10.1021/acs.inorgchem.8b00358
PMID:29611696
Abstract

New ruthenium methyl-cyclopentadienyl compounds bearing bipyridine derivatives with the general formula [Ru(η-MeCp)(PPh)(4,4'-R-2,2'-bpy)] (Ru1, R = H; Ru2, R = CH; and Ru3, R = CHOH) have been synthesized and characterized by spectroscopic and analytical techniques. Ru1 crystallized in the monoclinic P2/ c, Ru2 in the triclinic P1̅, and Ru3 in the monoclinic P2/ n space group. In all molecular structures, the ruthenium center adopts a "piano stool" distribution. Density functional theory calculations were performed for all complexes, and the results support spectroscopic data. Ru1 and Ru3 were poor substrates of the main multidrug resistance human pumps, ABCB1, ABCG2, ABCC1, and ABCC2, while Ru2 displayed inhibitory properties of ABCC1 and ABCC2 pumps. Importantly, all compounds displayed a very high cytotoxic profile for ovarian cancer cells (sensitive and resistant) that was much more pronounced than that observed with cisplatin, making them very promising anticancer agents.

摘要

新型钌甲基-环戊二烯基配合物,具有一般式[Ru(η-MeCp)(PPh)(4,4'-R-2,2'-bpy)]的联吡啶衍生物(Ru1,R = H;Ru2,R = CH;和 Ru3,R = CHOH),已通过光谱和分析技术进行了合成和表征。Ru1 结晶为单斜 P2/ c,Ru2 为三斜 P1̅,Ru3 为单斜 P2/ n 空间群。在所有分子结构中,钌中心采用“钢琴凳”分布。对所有配合物都进行了密度泛函理论计算,结果支持光谱数据。Ru1 和 Ru3 是主要多药耐药性人类泵(ABCB1、ABCG2、ABCC1 和 ABCC2)的不良底物,而 Ru2 对 ABCC1 和 ABCC2 泵具有抑制作用。重要的是,所有化合物对卵巢癌细胞(敏感和耐药)均表现出非常高的细胞毒性,比顺铂观察到的毒性更为明显,这使它们成为很有前途的抗癌药物。

相似文献

1
Methyl-cyclopentadienyl Ruthenium Compounds with 2,2'-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential.含 2,2'-联吡啶衍生物的甲基环戊二烯基钌化合物具有很强的抗癌活性和多药耐药潜力。
Inorg Chem. 2018 Apr 16;57(8):4629-4639. doi: 10.1021/acs.inorgchem.8b00358. Epub 2018 Apr 3.
2
The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds.共配体在新型钌(II)-环戊二烯基联吡啶衍生物中的关键作用:从无细胞毒性到高细胞毒性化合物
J Inorg Biochem. 2015 Sep;150:148-59. doi: 10.1016/j.jinorgbio.2015.06.015. Epub 2015 Jun 20.
3
Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand.新型含联吡啶-生物素配体的钌-环戊二烯基化合物对 P-糖蛋白活性的空前抑制作用。
Eur J Med Chem. 2019 Feb 1;163:853-863. doi: 10.1016/j.ejmech.2018.12.022. Epub 2018 Dec 12.
4
Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.采用 2,2'-联吡啶、氨基酸和一氧化氮衍生物的混合配体钌(II)配合物作为潜在抗癌药物提高乳腺癌细胞的细胞毒性。
Anticancer Agents Med Chem. 2021;21(12):1602-1611. doi: 10.2174/0929867327666201020155105.
5
Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.连接表皮生长因子受体(EGFR)抑制性4-苯胺基喹唑啉的钌(II)多吡啶配合物的合成、表征及体外抗肿瘤活性
Inorg Chem. 2016 May 2;55(9):4595-605. doi: 10.1021/acs.inorgchem.6b00309. Epub 2016 Apr 19.
6
A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.一种溶酶体靶向的钌(II)多吡啶配合物作为光动力抗癌剂。
J Inorg Biochem. 2020 Sep;210:111132. doi: 10.1016/j.jinorgbio.2020.111132. Epub 2020 Jun 10.
7
Effect of cobalt(II) complexes with dipyridylamine and salicylaldehydes on cultured tumor and non-tumor cells: synthesis, crystal structure investigations and biological activity.钴(II)配合物与二吡啶胺和水杨醛对培养的肿瘤和非肿瘤细胞的影响:合成、晶体结构研究和生物活性。
J Inorg Biochem. 2012 Dec;117:25-34. doi: 10.1016/j.jinorgbio.2012.08.022. Epub 2012 Sep 8.
8
Dinuclear Ru(bipy) Derivatives: Structural, Biological, and in Vivo Zebrafish Toxicity Evaluation.双核钌(联吡啶)衍生物:结构、生物学及斑马鱼体内毒性评估
Inorg Chem. 2017 Jun 19;56(12):7127-7144. doi: 10.1021/acs.inorgchem.7b00790. Epub 2017 Jun 6.
9
Novel family of [RuCp(N,N)(P)] compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies.新型[RuCp(N,N)(P)]配合物家族兼具抗癌和抗菌活性:生物学评价和溶液化学研究。
Eur J Med Chem. 2023 Dec 15;262:115922. doi: 10.1016/j.ejmech.2023.115922. Epub 2023 Oct 31.
10
New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives.用于抗癌活性的新型水溶性钌(II)三联吡啶配合物:合成、表征、活化动力学及与鸟嘌呤衍生物的相互作用
Inorg Chem. 2014 Jun 16;53(12):6113-26. doi: 10.1021/ic5005215. Epub 2014 Jun 2.

引用本文的文献

1
Metal-detection based techniques and their applications in metallobiology.基于金属检测的技术及其在金属生物学中的应用。
Chem Sci. 2024 Jun 6;15(27):10264-10280. doi: 10.1039/d4sc00108g. eCollection 2024 Jul 10.
2
Synthesis, anticancer activity, and molecular docking of half-sandwich iron(II) cyclopentadienyl complexes with maleimide and phosphine or phosphite ligands.半夹心型铁(II)茂基配合物与马来酰亚胺和膦或亚磷酸配体的合成、抗癌活性及分子对接。
Sci Rep. 2024 Mar 7;14(1):5634. doi: 10.1038/s41598-024-56339-0.
3
Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition.
用钌-环戊二烯化合物对抗多药耐药性:揭示 P-糖蛋白抑制的机制。
J Med Chem. 2023 Oct 26;66(20):14080-14094. doi: 10.1021/acs.jmedchem.3c01120. Epub 2023 Aug 24.
4
Effective and Selective Ru(II)-Arene Complexes Containing 4,4'-Substituted 2,2' Bipyridine Ligands Targeting Human Urinary Bladder Cancer Cells.含 4,4'-取代 2,2'联吡啶配体的有效且选择性的 Ru(II)-芳环配合物靶向人膀胱癌细胞。
Int J Mol Sci. 2023 Jul 25;24(15):11896. doi: 10.3390/ijms241511896.
5
Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model.生物素化聚合物-钌共轭物:三阴性乳腺癌模型的体外和体内研究
Pharmaceutics. 2022 Jun 30;14(7):1388. doi: 10.3390/pharmaceutics14071388.
6
Ruthenium(II)-Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs.钌(II)-环戊二烯基衍生物配合物作为新型抗结直肠癌药物
Pharmaceutics. 2022 Jun 17;14(6):1293. doi: 10.3390/pharmaceutics14061293.
7
Lipid Status of A2780 Ovarian Cancer Cells after Treatment with Ruthenium Complex Modified with Carbon Dot Nanocarriers: A Multimodal SR-FTIR Spectroscopy and MALDI TOF Mass Spectrometry Study.碳点纳米载体修饰的钌配合物处理后A2780卵巢癌细胞的脂质状态:多模态表面增强拉曼光谱-傅里叶变换红外光谱和基质辅助激光解吸电离飞行时间质谱研究
Cancers (Basel). 2022 Feb 24;14(5):1182. doi: 10.3390/cancers14051182.
8
Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.钌(II)茂环戊二烯配合物在乳腺癌细胞中的合成及生物学评价及对斑马鱼胚胎发育的影响。
Eur J Med Chem. 2020 Feb 15;188:112030. doi: 10.1016/j.ejmech.2019.112030. Epub 2020 Jan 3.